YBL-007

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameYBL-007

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionT lymphocytes stimulantsProgrammed death-ligand 1 blockersAntibody-dependent cell-mediated cytotoxicity (ADCC) effects

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesY-biologics Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesY-biologics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A